[Form 4] Medtronic plc Insider Trading Activity
Michael Marinaro, Executive Vice President, President MedSurg and Americas at Medtronic plc (MDT), reported a disposition of 1,052 ordinary shares on 08/20/2025. The shares were disposed at a reported price of $93.22 and the filing states this transaction represents shares withheld for payment of taxes upon vesting of previously reported restricted stock units. After the transaction, Marinaro beneficially owned 51,939 ordinary shares. The Form 4 is signed by an attorney-in-fact, Patricia Walesiewicz, dated 08/21/2025. The filing discloses only the withholding tax disposition and current beneficial ownership.
Michael Marinaro, Executive Vice President, President MedSurg and Americas di Medtronic plc (MDT), ha comunicato una cessione di 1.052 azioni ordinarie in data 20/08/2025. Le azioni sono state cedute a un prezzo segnalato di $93,22 e la dichiarazione specifica che questa operazione rappresenta azioni trattenute per il pagamento delle imposte al momento della maturazione di unit脿 azionarie vincolate precedentemente segnalate. Dopo la transazione, Marinaro possedeva beneficiariamente 51.939 azioni ordinarie. Il Modulo 4 猫 firmato da un procuratore, Patricia Walesiewicz, in data 21/08/2025. La comunicazione rivela solamente la cessione a titolo di ritenuta fiscale e la detenzione beneficiaria attuale.
Michael Marinaro, Vicepresidente Ejecutivo, Presidente MedSurg y Am茅ricas de Medtronic plc (MDT), inform贸 la disposici贸n de 1.052 acciones ordinarias el 20/08/2025. Las acciones se dispusieron a un precio informado de $93.22 y la presentaci贸n indica que esta operaci贸n representa acciones retenidas para el pago de impuestos al consolidarse unidades restringidas de acciones previamente reportadas. Tras la transacci贸n, Marinaro pose铆a beneficiariamente 51.939 acciones ordinarias. El Formulario 4 est谩 firmado por una apoderada, Patricia Walesiewicz, con fecha 21/08/2025. La presentaci贸n solo revela la disposici贸n por retenci贸n de impuestos y la propiedad beneficiaria actual.
Michael Marinaro電� Medtronic plc(MDT)鞚� Executive Vice President, President MedSurg and Americas搿滌劀 2025-08-20鞐� 1,052欤� 氤错喌欤�毳� 觳橂秳頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 鞁犼碃霅� 臧�瓴� $93.22鞐� 觳橂秳霅橃棃鞙茧┌, 氤搓碃靹滌棎電� 鞚� 瓯半灅臧� 鞚挫爠鞐� 氤搓碃霅� 鞝滍暅欤检嫕雼渼(RSU)臧� 旆摑霅� 霑� 氚滌儩頃� 靹戈笀 雮╇秬毳� 鞙勴暣 鞗愳矞歆曥垬霅� 欤检嫕鞚� 雮橅儉雮鸽嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 瓯半灅 鞚错泟 Marinaro電� 51,939欤� 氤错喌欤�毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. Form 4電� 雽�毽澑 Patricia Walesiewicz臧� 靹滊獏頄堨溂氅�, 靹滊獏鞚检潃 2025-08-21鞛呺媹雼�. 氤� 鞝滌稖靹滊姅 鞗愳矞歆曥垬 靹戈笀 觳橂秳瓿� 順勳灛 鞁れ 靻岇湢毵岇潉 瓿店皽頃橁碃 鞛堨姷雼堧嫟.
Michael Marinaro, Executive Vice President, President MedSurg and Americas chez Medtronic plc (MDT), a d茅clar茅 une cession de 1 052 actions ordinaires le 20/08/2025. Les actions ont 茅t茅 c茅d茅es 脿 un prix d茅clar茅 de 93,22 $ et le d茅p么t pr茅cise que cette op茅ration repr茅sente des actions retenues pour le paiement des imp么ts lors de l'acquisition d'unit茅s d'actions restreintes ant茅rieurement d茅clar茅es. Apr猫s la transaction, Marinaro d茅tenait b茅n茅ficiairement 51 939 actions ordinaires. Le formulaire 4 est sign茅 par une mandataire, Patricia Walesiewicz, dat茅 du 21/08/2025. Le d茅p么t divulgue uniquement la disposition li茅e 脿 la retenue fiscale et la propri茅t茅 b茅n茅ficiaire actuelle.
Michael Marinaro, Executive Vice President, President MedSurg and Americas bei Medtronic plc (MDT), meldete am 20.08.2025 die Ver盲u脽erung von 1.052 Stammaktien. Die Aktien wurden zu einem gemeldeten Preis von $93,22 ver盲u脽ert, und die Einreichung gibt an, dass diese Transaktion f眉r die Zahlung von Steuern einbehaltene Aktien im Zusammenhang mit der Aus眉bung zuvor gemeldeter Restricted Stock Units darstellt. Nach der Transaktion besa脽 Marinaro wirtschaftlich 51.939 Stammaktien. Das Formular 4 ist von einer Bevollm盲chtigten, Patricia Walesiewicz, unterzeichnet und datiert 21.08.2025. Die Meldung gibt nur die einbehaltene Steuerver盲u脽erung und die aktuelle wirtschaftliche Eigent眉merschaft an.
- Disclosure of tax-withholding disposal for vested restricted stock units provides transparency into executive equity changes
- Post-transaction beneficial ownership is reported (51,939 shares), giving a clear picture of remaining insider holdings
- Form 4 executed and signed by an authorized attorney-in-fact, indicating formal filing procedures were followed
- None.
Insights
TL;DR: Routine tax-withholding disposal of vested RSUs; small change relative to total holdings, limited market impact.
The Form 4 documents a common corporate practice where restricted stock units vest and the company withholds a portion of shares to satisfy tax obligations. The reported disposal of 1,052 shares at $93.22 reduced the reporting person's beneficial ownership to 51,939 shares. There is no indication of open-market selling for investment purposes or of additional derivative activity. For investors, this is administrative in nature and provides transparency on executive equity after vesting.
TL;DR: Proper Section 16 disclosure of tax-withholding on vested RSUs; filing appears complete for the disclosed transaction.
The Form 4 clearly identifies the reporting person, relationship to issuer, transaction date, and that the shares were withheld to pay taxes on vested RSUs. The entry includes the post-transaction beneficial ownership figure and is signed by an authorized attorney-in-fact. This meets routine Section 16 reporting expectations. No governance concerns, departures, or compensatory anomalies are noted within the provided text.
Michael Marinaro, Executive Vice President, President MedSurg and Americas di Medtronic plc (MDT), ha comunicato una cessione di 1.052 azioni ordinarie in data 20/08/2025. Le azioni sono state cedute a un prezzo segnalato di $93,22 e la dichiarazione specifica che questa operazione rappresenta azioni trattenute per il pagamento delle imposte al momento della maturazione di unit脿 azionarie vincolate precedentemente segnalate. Dopo la transazione, Marinaro possedeva beneficiariamente 51.939 azioni ordinarie. Il Modulo 4 猫 firmato da un procuratore, Patricia Walesiewicz, in data 21/08/2025. La comunicazione rivela solamente la cessione a titolo di ritenuta fiscale e la detenzione beneficiaria attuale.
Michael Marinaro, Vicepresidente Ejecutivo, Presidente MedSurg y Am茅ricas de Medtronic plc (MDT), inform贸 la disposici贸n de 1.052 acciones ordinarias el 20/08/2025. Las acciones se dispusieron a un precio informado de $93.22 y la presentaci贸n indica que esta operaci贸n representa acciones retenidas para el pago de impuestos al consolidarse unidades restringidas de acciones previamente reportadas. Tras la transacci贸n, Marinaro pose铆a beneficiariamente 51.939 acciones ordinarias. El Formulario 4 est谩 firmado por una apoderada, Patricia Walesiewicz, con fecha 21/08/2025. La presentaci贸n solo revela la disposici贸n por retenci贸n de impuestos y la propiedad beneficiaria actual.
Michael Marinaro電� Medtronic plc(MDT)鞚� Executive Vice President, President MedSurg and Americas搿滌劀 2025-08-20鞐� 1,052欤� 氤错喌欤�毳� 觳橂秳頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 鞁犼碃霅� 臧�瓴� $93.22鞐� 觳橂秳霅橃棃鞙茧┌, 氤搓碃靹滌棎電� 鞚� 瓯半灅臧� 鞚挫爠鞐� 氤搓碃霅� 鞝滍暅欤检嫕雼渼(RSU)臧� 旆摑霅� 霑� 氚滌儩頃� 靹戈笀 雮╇秬毳� 鞙勴暣 鞗愳矞歆曥垬霅� 欤检嫕鞚� 雮橅儉雮鸽嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 瓯半灅 鞚错泟 Marinaro電� 51,939欤� 氤错喌欤�毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. Form 4電� 雽�毽澑 Patricia Walesiewicz臧� 靹滊獏頄堨溂氅�, 靹滊獏鞚检潃 2025-08-21鞛呺媹雼�. 氤� 鞝滌稖靹滊姅 鞗愳矞歆曥垬 靹戈笀 觳橂秳瓿� 順勳灛 鞁れ 靻岇湢毵岇潉 瓿店皽頃橁碃 鞛堨姷雼堧嫟.
Michael Marinaro, Executive Vice President, President MedSurg and Americas chez Medtronic plc (MDT), a d茅clar茅 une cession de 1 052 actions ordinaires le 20/08/2025. Les actions ont 茅t茅 c茅d茅es 脿 un prix d茅clar茅 de 93,22 $ et le d茅p么t pr茅cise que cette op茅ration repr茅sente des actions retenues pour le paiement des imp么ts lors de l'acquisition d'unit茅s d'actions restreintes ant茅rieurement d茅clar茅es. Apr猫s la transaction, Marinaro d茅tenait b茅n茅ficiairement 51 939 actions ordinaires. Le formulaire 4 est sign茅 par une mandataire, Patricia Walesiewicz, dat茅 du 21/08/2025. Le d茅p么t divulgue uniquement la disposition li茅e 脿 la retenue fiscale et la propri茅t茅 b茅n茅ficiaire actuelle.
Michael Marinaro, Executive Vice President, President MedSurg and Americas bei Medtronic plc (MDT), meldete am 20.08.2025 die Ver盲u脽erung von 1.052 Stammaktien. Die Aktien wurden zu einem gemeldeten Preis von $93,22 ver盲u脽ert, und die Einreichung gibt an, dass diese Transaktion f眉r die Zahlung von Steuern einbehaltene Aktien im Zusammenhang mit der Aus眉bung zuvor gemeldeter Restricted Stock Units darstellt. Nach der Transaktion besa脽 Marinaro wirtschaftlich 51.939 Stammaktien. Das Formular 4 ist von einer Bevollm盲chtigten, Patricia Walesiewicz, unterzeichnet und datiert 21.08.2025. Die Meldung gibt nur die einbehaltene Steuerver盲u脽erung und die aktuelle wirtschaftliche Eigent眉merschaft an.
FAQ
What transaction did Michael Marinaro report on Form 4 for MDT?
At what price were the shares disposed according to the filing?
How many Medtronic shares does Marinaro beneficially own after the transaction?
Who signed the Form 4 and when was it signed?
Was the disposition described as a sale or another type of transaction?
